Cells communicate with their immediate environment in several ways; paracrine signaling specifically describes short-range release and local action, in contrast to endocrine signaling, which involves hormones traveling through circulation to distant targets.
The concept is central to how researchers describe the biology of perinatal tissue and cell-derived products in published literature. Composition findings do not establish a clinical effect; request analytical documentation for the specific product rather than relying on the general concept.
It is worth separating the general biological concept from any claim about a specific product. That a sample contains molecules associated with paracrine signaling is an analytical, compositional finding. It is not, by itself, a description of what using the product does in a clinical setting, which is a separate question for the treating physician and their own regulatory counsel.
Understanding paracrine signaling as a compositional concept, not a clinical outcome, helps buyers read supplier characterization data accurately.